Could a gut bacteria transplant ease heart failure in seniors?
NCT ID NCT07628777
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether transplanting healthy gut bacteria (fecal microbiota transplantation) can improve quality of life and exercise ability in elderly patients with a common type of heart failure (HFpEF). Fifty adults aged 60 and older will receive either the transplant or a placebo, while continuing standard heart failure care. The main goal is to see if the treatment boosts heart-related well-being after 20 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Air Force Medical University
Xi’an, Shanxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can shedding pounds reboot the Heart's exercise engine?
- Can a new pill ease the burden of heart failure with preserved pumping?
- Can a diabetes drug tame chronic heart failure? a Real-World study investigates
- Iron and folic acid: a simple pill that could ease anemia and heart symptoms?
- Heart rehab goes hybrid: can a mix of home and clinic sessions boost adherence?
- Keto vs. Low-Fat: which diet helps heart failure patients move better?